The DOI matches its Crossref record; 2,264 of the 2,264 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 2,264
The ‘magic tail’ of G protein‐coupled receptors: an anchorage for functional protein networks
Bockaert, J., Marin, P., Dumuis, A., & Fagni, L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00453-8 · Cited by 234
Self-citationDogrul, A., Ossipov, M. H., & Porreca, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.001 · Cited by 234
Neural Control of Energy Balance: Translating Circuits to Therapies
Gautron, L., Elmquist, J. K., & Williams, K. W. (2015) · Cell · doi:10.1016/j.cell.2015.02.023 · Cited by 234
5-HT6 receptors: a novel target for cognitive enhancement
Mitchell, E. S., & Neumaier, J. F. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.001 · Cited by 233
Self-citationGuscott, M., Bristow, L. J., Hadingham, K., Rosahl, T. W., Beer, M. S., Stanton, J. A., Bromidge, F., Owens, A. P., Huscroft, I., Myers, J., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.015 · Cited by 231
Self-citationFibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease
Antonini, A., & Poewe, W. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70218-1 · Cited by 231
Meller, E., Goldstein, M., & Bohmaker, K. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09962-6 · Cited by 231
A Role for Nuclear PTEN in Neuronal Differentiation
Lachyankar, M. B., Sultana, N., Schonhoff, C. M., Mitra, P., Poluha, W., Lambert, S., Quesenberry, P. J., Litofsky, N. S., Recht, L. D., Nabi, R., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01404.2000 · Cited by 230
Wesołowska, A., Nikiforuk, A., Stachowicz, K., & Tatarczyńska, E. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.017 · Cited by 230
Behavioral Satiety Sequence (BSS) for the Diagnosis of Drug Action on Food Intake
Halford, J. C. G., Wanninayake, S. C. D., & Blundell, J. E. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00032-x · Cited by 230
The Concise Guide to PHARMACOLOGY 2015/16: Overview
Alexander, S. P., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., Buneman, O. P., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13347 · Cited by 230
Béïque, J.-C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700436104 · Cited by 229
Cdk5 Phosphorylation of Doublecortin Ser297 Regulates Its Effect on Neuronal Migration
Tanaka, T., Serneo, F. F., Tseng, H.-C., Kulkarni, A. B., Tsai, L.-H., & Gleeson, J. G. (2004) · Neuron · doi:10.1016/s0896-6273(03)00852-3 · Cited by 229
Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
Schmid, C. L., Raehal, K. M., & Bohn, L. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708862105 · Cited by 229
A subfamily of 5-HT1D receptor genes
Hartig, P. R., Branchek, T. A., & Weinshank, R. L. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90053-9 · Cited by 229
Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis
Berglund, E. D., Liu, C., Sohn, J.-W., Liu, T., Kim, M. H., Lee, C. E., Vianna, C. R., Williams, K. W., Xu, Y., & Elmquist, J. K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70338 · Cited by 229
Role of ventral medial prefrontal cortex in incubation of cocaine craving
Koya, E., Uejima, J. L., Wihbey, K. A., Bossert, J. M., Hope, B. T., & Shaham, Y. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.022 · Cited by 229
Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.
Hamblin, M. W., & Metcalf, M. A. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12918-0 · Cited by 228
Parsey, R. V., Olvet, D. M., Oquendo, M. A., Huang, Y.-Y., Ogden, R. T., & Mann, J. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300992 · Cited by 227
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study
Newman-Tancredi, A., Gavaudan, S., Conte, C., Chaput, C., Touzard, M., Verrièle, L., Audinot, V., & Millan, M. J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00483-x · Cited by 227
Self-citationKvachnina, E., Liu, G., Dityatev, A., Renner, U., Dumuis, A., Richter, D. W., Dityateva, G., Schachner, M., Voyno-Yasenetskaya, T. A., & Ponimaskin, E. G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1790-05.2005 · Cited by 227
Rapid modulation of spine morphology by the 5-HT 2A serotonin receptor through kalirin-7 signaling
Jones, K. A., Srivastava, D. P., Allen, J. A., Strachan, R. T., Roth, B. L., & Penzes, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905884106 · Cited by 226
Self-citationMengod, G., Nguyen, H., Le, H., Waeber, C., Lübbert, H., & Palacios, J. M. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90330-7 · Cited by 226
5-HT1A receptor-regulated signal transduction pathways in brain
Polter, A. M., & Li, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.019 · Cited by 225
Alvarez, E., Perez, V., Dragheim, M., Loft, H., & Artigas, F. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001027 · Cited by 225
Keegan, A., Morecroft, I., Smillie, D., Hicks, M. N., & MacLean, M. R. (2001) · Circulation Research · doi:10.1161/hh2401.100426 · Cited by 225
Characterization and distribution of putative 5‐ht7receptors in guinea‐pig brain
To, Z. P., Bonhaus, D. W., Eglen, R. M., & Jakeman, L. B. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16327.x · Cited by 225
Gut-Derived Serotonin Is a Multifunctional Determinant to Fasting Adaptation
Sumara, G., Sumara, O., Kim, J. K., & Karsenty, G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.014 · Cited by 224
Selvaraj, S., Arnone, D., Cappai, A., & Howes, O. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.005 · Cited by 223
O'Connell, P. J., Wang, X., Leon-Ponte, M., Griffiths, C., Pingle, S. C., & Ahern, G. P. (2006) · Blood · doi:10.1182/blood-2005-07-2903 · Cited by 223
Self-citationMaroteaux, L., Saudou, F., Amlaiky, N., Boschert, U., Plassat, J. L., & Hen, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3020 · Cited by 223
Self-citationLappalainen, J., Zhang, L., Dean, M., Oz, M., Ozaki, N., Yu, D.-H., Virkkunen, M., Weight, F., Linnoila, M., & Goldman, D. (1995) · Genomics · doi:10.1006/geno.1995.1042 · Cited by 222
Schechter, L. E., Lin, Q., Smith, D. L., Zhang, G., Shan, Q., Platt, B., Brandt, M. R., Dawson, L. A., Cole, D., Bernotas, R., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301503 · Cited by 222
Serotonin promotes tumor growth in human hepatocellular cancer†
Soll, C., Jang, J. H., Riener, M., Moritz, W., Wild, P. J., Graf, R., & Clavien, P. (2010) · Hepatology · doi:10.1002/hep.23441 · Cited by 222
Sari, Y., Miquel, M.-C., Brisorgueil, M.-J., Ruiz, G., Doucet, E., Hamon, M., & Vergé, D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00256-5 · Cited by 222
Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease
Ebrahimkhani, M. R., Oakley, F., Murphy, L. B., Mann, J., Moles, A., Perugorria, M. J., Ellis, E., Lakey, A. F., Burt, A. D., Douglass, A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2490 · Cited by 221
Self-citationHeidmann, D. E. A., Metcalf, M. A., Kohen, R., & Hamblin, M. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041372.x · Cited by 221
Sealfon, S. C., Chi, L., Ebersole, B. J., Rodic, V., Zhang, D., Ballesteros, J. A., & Weinstein, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16683 · Cited by 221
Longmore, J., Shaw, D., Smith, D., Hopkins, R., McAlliste, G., Pickard, J., Sirinathsinghji, D., Butler, A., & Hill, R. (1997) · Cephalalgia · doi:10.1046/j.1468-2982.1997.1708833.x · Cited by 221
Voigt, M. M., Laurie, D. J., Seeburg, P. H., & Bach, A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04977.x · Cited by 220
Felder, C. C., Kanterman, R. Y., Ma, A. L., & Axelrod, J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2187 · Cited by 220
Yuan, X., Yamada, K., Ishiyama-Shigemoto, S., Koyama, W., & Nonaka, K. (2000) · Diabetologia · doi:10.1007/s001250050056 · Cited by 219
Hirst, W. D., Abrahamsen, B., Blaney, F. E., Calver, A. R., Aloj, L., Price, G. W., & Medhurst, A. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1295 · Cited by 219
Winstanley, C. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01323.x · Cited by 218
Di Giovanni, G., De Deurwaerdére, P., Di Mascio, M., Di Matteo, V, Esposito, E., & Spampinato, U. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00655-1 · Cited by 218
Self-citationMaura, G., & Raiteri, M. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90443-7 · Cited by 218
5-Hydroxytryptamine and cardiovascular regulation
RAMAGE, A., & VILLALON, C. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.009 · Cited by 218
Cryo-EM structure of the serotonin 5-HT1B receptor coupled to heterotrimeric Go
García-Nafría, J., Nehmé, R., Edwards, P. C., & Tate, C. G. (2018) · Nature · doi:10.1038/s41586-018-0241-9 · Cited by 217
Nilsson, T., Longmore, J., Shaw, D., Pantev, E., Bard, J. A., Branchek, T., & Edvinsson, L. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00114-4 · Cited by 215
Bliziotes, M. M., Eshleman, A. J., Zhang, X.-W., & Wiren, K. M. (2001) · Bone · doi:10.1016/s8756-3282(01)00593-2 · Cited by 215
Katz, M., DeRogatis, L. R., Ackerman, R., Hedges, P., Lesko, L., Garcia, M., & Sand, M. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12189 · Cited by 215
Prisco, S., Pagannone, S., & Esposito, E. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22843-9 · Cited by 214
Bhagwagar, Z., Hinz, R., Taylor, M., Fancy, S., Cowen, P., & Grasby, P. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1580 · Cited by 214
Zhou, L., Sutton, G. M., Rochford, J. J., Semple, R. K., Lam, D. D., Oksanen, L. J., Thornton-Jones, Z. D., Clifton, P. G., Yueh, C.-Y., Evans, M. L., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.008 · Cited by 213
Reversal of hippocampal neuronal maturation by serotonergic antidepressants
Kobayashi, K., Ikeda, Y., Sakai, A., Yamasaki, N., Haneda, E., Miyakawa, T., & Suzuki, H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912690107 · Cited by 212
Association of the C(–1019)G 5-HT1A functional promoter polymorphism with antidepressant response
Lemonde, S., Du, L., Bakish, D., Hrdina, P., & Albert, P. R. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004699 · Cited by 212
Dürk, T., Panther, E., Müller, T., Sorichter, S., Ferrari, D., Pizzirani, C., Di Virgilio, F., Myrtek, D., Norgauer, J., & Idzko, M. (2005) · International Immunology · doi:10.1093/intimm/dxh242 · Cited by 212
Fletcher, P. J., Tampakeras, M., Sinyard, J., & Higgins, G. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0891-z · Cited by 211
Activation of Intrinsic Afferent Pathways in Submucosal Ganglia of the Guinea Pig Small Intestine
Pan, H., & Gershon, M. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03295.2000 · Cited by 211
Self-citationStudies to Investigate the Role of 5-HT2C Receptors on Cocaine- and Food-Maintained Behavior
Grottick, A. J., Fletcher, P. J., & Higgins, G. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39021-4 · Cited by 211
Preclinical pharmacological profile of the selective 5-HT1Freceptor agonist lasmiditan
Nelson, D. L., Phebus, L. A., Johnson, K. W., Wainscott, D. B., Cohen, M. L., Calligaro, D. O., & Xu, Y.-C. (2010) · Cephalalgia · doi:10.1177/0333102410370873 · Cited by 211
Self-citationMatthes, H., Boschert, U., Amlaiky, N., Grailhe, R., Plassat, J. L., Muscatelli, F., Mattei, M. G., & Hen, R. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13615-8 · Cited by 210
Duxon, M. S., Flanigan, T. P., Reavley, A. C., Baxter, G. S., Blackburn, T. P., & Fone, K. C. F. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00480-0 · Cited by 210
Self-citationTreatment of nausea and vomiting: Gaps in our knowledge
Sanger, G. J., & Andrews, P. L. R. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.07.009 · Cited by 209
Self-citationDifferential Involvement of Gα12 and Gα13 in Receptor-mediated Stress Fiber Formation
Gohla, A., Offermanns, S., Wilkie, T. M., & Schultz, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17901 · Cited by 209
Villalón, C. M., & Olesen, J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.09.003 · Cited by 209
Self-citationBockaert, J., Claeysen, S., Compan, V, & Dumuis, A. (2004) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007043482615 · Cited by 209
Self-citationMayorga, A. J., Dalvi, A., Page, M. E., Zimov-Levinson, S., Hen, R., & Lucki, I. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29479-9 · Cited by 209
5‐Hydroxytryptamine participation in the vagal inhibitory innervation of the stomach
Bülbring, E., & Gershon, M. D. (1967) · The Journal of Physiology · doi:10.1113/jphysiol.1967.sp008334 · Cited by 208
Self-citationAndresen, V., Montori, V. M., Keller, J., West, C. P., Layer, P., & Camilleri, M. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.12.015 · Cited by 208
Self-citationViñals, X., Moreno, E., Lanfumey, L., Cordomí, A., Pastor, A., de La Torre, R., Gasperini, P., Navarro, G., Howell, L. A., Pardo, L., et al. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002194 · Cited by 207
Sumiyoshi, T., Matsui, M., Nohara, S., Yamashita, I., Kurachi, M., Sumiyoshi, C., Jayathilake, K., & Meltzer, H. Y. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1722 · Cited by 207
Bischoff, S. C., Mailer, R., Pabst, O., Weier, G., Sedlik, W., Li, Z., Chen, J. J., Murphy, D. L., & Gershon, M. D. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90685.2008 · Cited by 206
Abdul-Monim, Z., Neill, J. C., & Reynolds, G. P. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107067097 · Cited by 206
Guignabert, C., Raffestin, B., Benferhat, R., Raoul, W., Zadigue, P., Rideau, D., Hamon, M., Adnot, S., & Eddahibi, S. (2005) · Circulation · doi:10.1161/circulationaha.104.524926 · Cited by 206
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze
Woolley, M. L., Bentley, J. C., Sleight, A. J., Marsden, C. A., & Fone, K. C. F. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00056-9 · Cited by 206
Self-citationExpression of Serotonin Receptors in Bone
Westbroek, I., van der Plas, A., de Rooij, K. E., Klein-Nulend, J., & Nijweide, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101824200 · Cited by 206
Weber (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00036 · Cited by 205
Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907
López-Giménez, J. F., Mengod, G., Palacios, J. M., & Vilaró, M. T. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005075 · Cited by 205
Christianson, J. P., Ragole, T., Amat, J., Greenwood, B. N., Strong, P. V., Paul, E. D., Fleshner, M., Watkins, L. R., & Maier, S. F. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.011 · Cited by 204
A 5‐hydroxytryptamine receptor in human atrium
Kaumann, A. J., Sanders, L., Brown, A. M., Murray, K. J., & Brown, M. J. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14108.x · Cited by 204
Absence of Fyn and Src Causes a Reeler-Like Phenotype
Kuo, G., Arnaud, L., Kronstad-O'Brien, P., & Cooper, J. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1656-05.2005 · Cited by 204
Neumaier, J. F., Sexton, T. J., Yracheta, J., Diaz, A. M., & Brownfield, M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00092-2 · Cited by 204
Self-citationVanover, K. E., Weiner, D. M., Makhay, M., Veinbergs, I., Gardell, L. R., Lameh, J., Del Tredici, A. L., Piu, F., Schiffer, H. H., Ott, T. R., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097006 · Cited by 204
Serotonin Transporter Inhibitors Protect against Hypoxic Pulmonary Hypertension
Marcos, E., Adnot, S., Pham, M. H., Nosjean, A., Raffestin, B., Hamon, M., & Eddahibi, S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1212oc · Cited by 204
5-Hydroxytryptamine2A Receptor Inverse Agonists as Antipsychotics
Weiner, D. M., Burstein, E. S., Nash, N., Croston, G. E., Currier, E. A., Vanover, K. E., Harvey, S. C., Donohue, E., Hansen, H. C., Andersson, C. M., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29327-7 · Cited by 203
Engel, G., G�thert, M., M�ller-Schweinitzer, E., Schlicker, E., Sistonen, L., & Stadler, P. A. (1983) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00497016 · Cited by 203
Puig, M. V., Watakabe, A., Ushimaru, M., Yamamori, T., & Kawaguchi, Y. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3335-09.2010 · Cited by 203
5-HT3 receptors: Role in disease and target of drugs
Walstab, J., Rappold, G., & Niesler, B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.001 · Cited by 203
Lübbert, H., Hoffman, B. J., Snutch, T. P., van Dyke, T., Levine, A. J., Hartig, P. R., Lester, H. A., & Davidson, N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.12.4332 · Cited by 202
Pehek, E. A., Nocjar, C., Roth, B. L., Byrd, T. A., & Mabrouk, O. S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300819 · Cited by 202
Self-citationVan De Kar, L. D., & Lorens, S. A. (1979) · Brain Research · doi:10.1016/0006-8993(79)90754-6 · Cited by 202
Increased Exploratory Activity and Altered Response to LSD in Mice Lacking the 5-HT5A Receptor
Grailhe, R., Waeber, C., Dulawa, S. C., Hornung, J. P., Zhuang, X., Brunner, D., Geyer, M. A., & Hen, R. (1999) · Neuron · doi:10.1016/s0896-6273(00)80712-6 · Cited by 202
Bockaert, J., Sebben, M., & Dumuis, A. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10829-8 · Cited by 202
Self-citationKendall, D. A., & Nahorski, S. R. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21236-8 · Cited by 202
Propulsion in Guinea Pig Colon Induced by 5-Hydroxytryptamine (HT) via 5-HT4 and 5-HT3 Receptors
Jin, J.-G., Foxx-Orenstein, A. E., & Grider, J. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37929-7 · Cited by 202
5-HT Receptors: Subtypes and Second Messengers
Hoyer, D., & Schoeffter, P. (1991) · Journal of Receptor Research · doi:10.3109/10799899109066399 · Cited by 201
Self-citation5-HT2B receptors are required for serotonin-selective antidepressant actions
Diaz, S. L., Doly, S., Narboux-Nême, N., Fernández, S., Mazot, P., Banas, S. M., Boutourlinsky, K., Moutkine, I., Belmer, A., Roumier, A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.159 · Cited by 200
Self-citationWeissmann-Nanopoulos, D., Mach, E., Magre, J., Demassey, Y., & Pujol, J.-F. (1985) · Neurochemistry International · doi:10.1016/0197-0186(85)90156-1 · Cited by 200
Rammes, G., Rupprecht, R., Ferrari, U., Zieglgänsberger, W., & Parsons, C. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01872-9 · Cited by 200
Sorting Nexins – Unifying Trends and New Perspectives
Carlton, J., Bujny, M., Rutherford, A., & Cullen, P. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00260.x · Cited by 199
5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus
Markstein, R., Hoyer, D., & Engel, G. (1986) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00500006 · Cited by 199
Self-citationWard, R. P., Hamblin, M. W., Lachowicz, J. E., Hoffman, B. J., Sibley, D. R., & Dorsa, D. M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00439-c · Cited by 198
Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration
Hensler, J. G. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02482-7 · Cited by 198
Reynolds, G. P., Zhang, Z., & Zhang, X. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.677 · Cited by 198
Claeysen, S., Sebben, M., Becamel, C., Bockaert, J., & Dumuis, A. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23188-6 · Cited by 197
Self-citationBinding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors.
Roth, B. L., Ciaranello, R. D., & Meltzer, H. Y. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11452-3 · Cited by 197
Self-citationBertrand, P. P., Kunze, W. A. A., Furness, J. B., & Bornstein, J. C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00363-8 · Cited by 197
Renner, U., Zeug, A., Woehler, A., Niebert, M., Dityatev, A., Dityateva, G., Gorinski, N., Guseva, D., Abdel-Galil, D., Fröhlich, M., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.101337 · Cited by 197
Wang, Q., O'Brien, P. J., Chen, C., Cho, D. C., Murray, J. M., & Nishikura, K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741290.x · Cited by 197
Jean, A., Conductier, G., Manrique, C., Bouras, C., Berta, P., Hen, R., Charnay, Y., Bockaert, J., & Compan, V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701471104 · Cited by 197
Self-citationThe phospholipase D superfamily as therapeutic targets
Frohman, M. A. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.01.001 · Cited by 196
Ward, R. P., & Dorsa, D. M. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960701)370:3<405::aid-cne10>3.0.co;2-r · Cited by 196
Sohn, J.-W., Xu, Y., Jones, J. E., Wickman, K., Williams, K. W., & Elmquist, J. K. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.012 · Cited by 196
Serotonin receptors: guardians of stable breathing
Richter, D. W., Manzke, T., Wilken, B., & Ponimaskin, E. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.10.010 · Cited by 196
Guignabert, C., Izikki, M., Tu, L. I., Li, Z., Zadigue, P., Barlier-Mur, A.-M., Hanoun, N., Rodman, D., Hamon, M., Adnot, S., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000222546.45372.a0 · Cited by 196
Tang, L., Todd, R. D., Heller, A., & O'Malley, K. L. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38500-9 · Cited by 196
Cloning and functional characterization of the rat stomach fundus serotonin receptor.
Foguet, M., Hoyer, D., Pardo, L. A., Parekh, A., Kluxen, F. W., Kalkman, H. O., Stühmer, W., & Lübbert, H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05427.x · Cited by 195
Self-citationLeptin Excites Proopiomelanocortin Neurons via Activation of TRPC Channels
Qiu, J., Fang, Y., Rønnekleiv, O. K., & Kelly, M. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4816-09.2010 · Cited by 195
Human mast cells are capable of serotonin synthesis and release
Kushnir-Sukhov, N. M., Brown, J. M., Wu, Y., Kirshenbaum, A., & Metcalfe, D. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.09.003 · Cited by 195
Arslan, A. A., Gold, L. I., Mittal, K., Suen, T.-C., Belitskaya-Levy, I., Tang, M.-S., & Toniolo, P. (2005) · Human Reproduction · doi:10.1093/humrep/deh698 · Cited by 195
Kapeller, J., Houghton, L. A., Mönnikes, H., Walstab, J., Möller, D., Bönisch, H., Burwinkel, B., Autschbach, F., Funke, B., Lasitschka, F., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn195 · Cited by 195
Cellular localization of serotonin2A (5HT2A) receptors in the rat brain
Xu, T., & Pandey, S. C. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00278-6 · Cited by 194
A Role for Serotonin (5-HT) in Hepatic Stellate Cell Function and Liver Fibrosis
Ruddell, R. G., Oakley, F., Hussain, Z., Yeung, I., Bryan-Lluka, L. J., Ramm, G. A., & Mann, D. A. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050767 · Cited by 194
Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain
Waeber, C., Sebben, M., Nieoullon, A., Bockaert, J., & Dumuis, A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90084-1 · Cited by 193
Self-citationLorcaserin (APD356), a Selective 5‐HT2CAgonist, Reduces Body Weight in Obese Men and Women
Smith, S. R., Prosser, W. A., Donahue, D. J., Morgan, M. E., Anderson, C. M., Shanahan, W. R., & APD356‐004 Study Group (2009) · Obesity · doi:10.1038/oby.2008.537 · Cited by 192
8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents
Hedlund, P. B., Kelly, L., Mazur, C., Lovenberg, T., Sutcliffe, J. G., & Bonaventure, P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.031 · Cited by 192
Richardson-Jones, J. W., Craige, C. P., Nguyen, T. H., Kung, H. F., Gardier, A. M., Dranovsky, A., David, D. J., Guiard, B. P., Beck, S. G., Hen, R., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5836-10.2011 · Cited by 192
Conn, P. J., & Sanders-Bush, E. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90017-0 · Cited by 192
Villalón, C. M., & Centurión, D. (2007) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-007-0179-1 · Cited by 192
Self-citationDurgam, S., Starace, A., Li, D., Migliore, R., Ruth, A., Németh, G., & Laszlovszky, I. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.11.041 · Cited by 192
Hamon, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00044-5 · Cited by 191
Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial
Nakamura, M., Ogasa, M., Guarino, J., Phillips, D., Severs, J., Cucchiaro, J., & Loebel, A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04905 · Cited by 191
Margolis, K. G., Stevanovic, K., Li, Z., Yang, Q. M., Oravecz, T., Zambrowicz, B., Jhaver, K. G., Diacou, A., & Gershon, M. D. (2014) · Gut · doi:10.1136/gutjnl-2013-304901 · Cited by 191
Self-citationImportant messages in the ‘post’: recent discoveries in 5-HT neurone feedback control
Sharp, T., Boothman, L., Raley, J., & Quérée, P. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.009 · Cited by 190
Self-citationLecoutey, C., Hédou, D., Fréret, T., Giannoni, P., Gaven, F., Since, M., Bouët, V., Ballandonne, C., Corvaisier, S., Malzert‐Fréon, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410315111 · Cited by 190
Self-citationFulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism
Luttrell, L. M., Maudsley, S., & Bohn, L. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099630 · Cited by 190
Motor Dysfunction of the Small Bowel and Colon in Patients with the Carcinoid Syndrome and Diarrhea
Ohe, M. R. V. D., Camilleri, M., Kvols, L. K., & Thomforde, G. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310073291503 · Cited by 189
Self-citationCloning and characterization of MUPP1, a novel PDZ domain protein
Ullmer, C., Schmuck, K., Figge, A., & Lübbert, H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00141-0 · Cited by 189
Foxx-Orenstein, A., Kuemmerle, J., & Grider, Jr. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8898642 · Cited by 188
Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex
Tanaka, E., & North, R. A. (1993) · Journal of Neurophysiology · doi:10.1152/jn.1993.69.5.1749 · Cited by 188
Kursar, J. D., Nelson, D. L., Wainscott, D. B., Cohen, M. L., & Baez, M. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08969-2 · Cited by 186
Self-citation5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesis
Costall, B., Domeney, A. M., Naylor, R. J., & Tattersall, F. D. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90030-4 · Cited by 186
Färkkilä, M., Diener, H.-C., Géraud, G., Láinez, M., Schoenen, J., Harner, N., Pilgrim, A., & Reuter, U. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70047-9 · Cited by 186
DeRogatis, L. R., Komer, L., Katz, M., Moreau, M., Kimura, T., Garcia Jr., M., Wunderlich, G., & Pyke, R. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02626.x · Cited by 186
Chen, J.-X., Pan, H., Rothman, T. P., Wade, P. R., & Gershon, M. D. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.3.g433 · Cited by 186
Self-citationDi Matteo, V., Di Giovanni, G., Di Mascio, M., & Esposito, E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02246-0 · Cited by 184
Self-citationHeal, D. J., Smith, S. L., Fisas, A., Codony, X., & Buschmann, H. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.08.006 · Cited by 184
Erlander, M. G., Lovenberg, T. W., Baron, B. M., de Lecea, L., Danielson, P. E., Racke, M., Slone, A. L., Siegel, B. W., Foye, P. E., & Cannon, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3452 · Cited by 184
Anxiety as a Developmental Disorder
Leonardo, E. D., & Hen, R. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301569 · Cited by 183
Thomas, D., & Hagan, J. (2004) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007043482633 · Cited by 183
Nebigil, C. G., Launay, J.-M., Hickel, P., Tournois, C., & Maroteaux, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050282397 · Cited by 183
Self-citationBuspirone in Levodopa-Induced Dyskinesias
Bonifati, V., Fabrizio, E., Cipriani, R., Vanacore, N., & Meco, G. (1994) · Clinical Neuropharmacology · doi:10.1097/00002826-199402000-00008 · Cited by 181
Prisco, S., & Esposito, E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16684.x · Cited by 181
No hypothermic response to serotonin in 5-HT 7 receptor knockout mice
Hedlund, P. B., Danielson, P. E., Thomas, E. A., Slanina, K., Carson, M. J., & Sutcliffe, J. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337340100 · Cited by 181
Miyake, A., Mochizuki, S., Takemoto, Y., & Akuzawa, S. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10488-4 · Cited by 181
Serotonin alterations in anorexia and bulimia nervosa: New insights from imaging studies
KAYE, W., FRANK, G., BAILER, U., HENRY, S., MELTZER, C., PRICE, J., MATHIS, C., & WAGNER, A. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.04.013 · Cited by 181
Bourson, A., Borroni, E., Austin, R. H., Monsma, F. J., & Sleight, A. J. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10539-9 · Cited by 181
Herrick‐Davis, K., Grinde, E., & Niswender, C. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.731711.x · Cited by 180
Self-citationSleight, A. J., Boess, F. G., Bös, M., Levet‐Trafit, B., Riemer, C., & Bourson, A. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701851 · Cited by 180
Separate systems for serotonin and leptin in appetite control
Halford, J. C. G., & Blundell, J. E. (2000) · Annals of Medicine · doi:10.3109/07853890008998829 · Cited by 180
PRIOR, A., & READ, N. W. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00087.x · Cited by 180
Aznar, S., Qian, Z., Shah, R., Rahbek, B., & Knudsen, G. M. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03727-7 · Cited by 180
Cloning and Expression of a 5‐Hydroxytryptamine7 Receptor Positively Coupled to Adenylyl Cyclase
Tsou, A., Kosaka, A., Bach, C., Zuppan, P., Yee, C., Tom, L., Alvarez, R., Ramsey, S., Bonhaus, D. W., Stefanich, E., et al. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020456.x · Cited by 180
Higgins, G. A., Enderlin, M., Haman, M., & Fletcher, P. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1549-0 · Cited by 179
Leonhardt, S., Herrick‐Davis, K., & Titeler, M. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07357.x · Cited by 179
Self-citationOu, X.-M., Storring, J. M., Kushwaha, N., & Albert, P. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005363200 · Cited by 178
Compan, V., Zhou, M., Grailhe, R., Gazzara, R. A., Martin, R., Gingrich, J., Dumuis, A., Brunner, D., Bockaert, J., & Hen, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2806-03.2004 · Cited by 178
Self-citationKetamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism
Gigliucci, V., O’Dowd, G., Casey, S., Egan, D., Gibney, S., & Harkin, A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3024-x · Cited by 177
Doherty, M. D., & Pickel, V. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02062-x · Cited by 177
De Vry, J., Benz, U., Schreiber, R., & Traber, J. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90530-u · Cited by 176
Schmid, C. L., & Bohn, L. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1665-10.2010 · Cited by 175
Neurochemical profiles of some novel psychoactive substances
Iversen, L., Gibbons, S., Treble, R., Setola, V., Huang, X.-P., & Roth, B. L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.12.006 · Cited by 175
Self-citationOlanow, C. W., Damier, P., Goetz, C. G., Mueller, T., Nutt, J., Rascol, O., Serbanescu, A., Deckers, F., & Russ, H. (2004) · Clinical Neuropharmacology · doi:10.1097/00002826-200403000-00003 · Cited by 175
GPCR Interacting Proteins (GIPs) in the Nervous System: Roles in Physiology and Pathologies
Bockaert, J., Perroy, J., Bécamel, C., Marin, P., & Fagni, L. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105705 · Cited by 175
Self-citationHegde, S. S., & Eglen, R. M. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.12.8903510 · Cited by 174
Krabbe, G., Matyash, V., Pannasch, U., Mamer, L., Boddeke, H. W. G. M., & Kettenmann, H. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.12.002 · Cited by 174
p11 and its role in depression and therapeutic responses to antidepressants
Svenningsson, P., Kim, Y., Warner-Schmidt, J., Oh, Y.-S., & Greengard, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3564 · Cited by 174
Correction of respiratory disorders in a mouse model of Rett syndrome
Abdala, A. P. L., Dutschmann, M., Bissonnette, J. M., & Paton, J. F. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012104107 · Cited by 174
Cogolludo, A., Moreno, L., Lodi, F., Frazziano, G., Cobeño, L., Tamargo, J., & Perez-Vizcaino, F. (2006) · Circulation Research · doi:10.1161/01.res.0000216858.04599.e1 · Cited by 174
Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors
Leggett, J. D., Aspley, S., Beckett, S. R. G., D'Antona, A. M., Kendall, D. A., & Kendall, D. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705607 · Cited by 174
Synaptic multiprotein complexes associated with 5-HT2C receptors: a proteomic approach
Becamel, C. (2002) · The EMBO Journal · doi:10.1093/emboj/21.10.2332 · Cited by 173
Self-citationInverse Agonist Activity of Atypical Antipsychotic Drugs at Human 5-Hydroxytryptamine2C Receptors
Herrick-Davis, K., Grinde, E., & Teitler, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38891-3 · Cited by 173
Self-citationSerafeim, A., Holder, M. J., Grafton, G., Chamba, A., Drayson, M. T., Luong, Q. T., Bunce, C. M., Gregory, C. D., Barnes, N. M., & Gordon, J. (2003) · Blood · doi:10.1182/blood-2002-07-2044 · Cited by 173
Self-citationRhoA and Rho Kinase Activation in Human Pulmonary Hypertension: Role of 5-HT Signaling
Guilluy, C., Eddahibi, S., Agard, C., Guignabert, C., Izikki, M., Tu, L., Savale, L., Humbert, M., Fadel, E., Adnot, S., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-691oc · Cited by 172
Bécamel, C., Figge, A., Poliak, S., Dumuis, A., Peles, E., Bockaert, J., Lübbert, H., & Ullmer, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008089200 · Cited by 172
Self-citation5‐HT 6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
Meffre, J., Chaumont‐Dubel, S., Mannoury la Cour, C., Loiseau, F., Watson, D. J. G., Dekeyne, A., Séveno, M., Rivet, J., Gaven, F., Déléris, P., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201410 · Cited by 172
Self-citationThomas, E. A., Cravatt, B. F., Danielson, P. E., Gilula, N. B., & Sutcliffe, J. G. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971215)50:6<1047::aid-jnr16>3.0.co;2-1 · Cited by 172
Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?
Meltzer, H. Y., & Sumiyoshi, T. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.05.016 · Cited by 172
Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group
Nocjar, C., Roth, B. L., & Pehek, E. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00593-0 · Cited by 171
Self-citationBhatnagar, A., Sheffler, D. J., Kroeze, W. K., Compton-Toth, B., & Roth, B. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404673200 · Cited by 171
Self-citationWillins, D. L., Berry, S. A., Alsayegh, L., Backstrom, J. R., Sanders-Bush, E., Friedman, L., & Roth, B. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00653-8 · Cited by 171
Self-citationDecreased tryptophan metabolism in patients with autism spectrum disorders
Boccuto, L., Chen, C.-F., Pittman, A. R., Skinner, C. D., McCartney, H. J., Jones, K., Bochner, B. R., Stevenson, R. E., & Schwartz, C. E. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-16 · Cited by 171
Bouchelet, I., Cohen, Z., Case, B., Séguéla, P., & Hamel, E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09209-0 · Cited by 171
Adham, N., Romanienko, P., Hartig, P., Weinshank, R. L., & Branchek, T. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08798-x · Cited by 171
Structural determinants of 5-HT2B receptor activation and biased agonism
McCorvy, J. D., Wacker, D., Wang, S., Agegnehu, B., Liu, J., Lansu, K., Tribo, A. R., Olsen, R. H. J., Che, T., Jin, J., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0116-7 · Cited by 171
Self-citationKursar, J. D., Nelson, D. L., Wainscott, D. B., & Baez, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09676-2 · Cited by 170
Self-citationDifferent properties of the central and peripheral forms of human tryptophan hydroxylase
McKinney, J., Knappskog, P. M., & Haavik, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02850.x · Cited by 170
Viguier, F., Michot, B., Hamon, M., & Bourgoin, S. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.074 · Cited by 170
Popa, D., Léna, C., Fabre, V., Prenat, C., Gingrich, J., Escourrou, P., Hamon, M., & Adrien, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1724-05.2005 · Cited by 170
Cited by
Tryptophan metabolism and gut-brain homeostasis
Roth, W., Zadeh, K., Vekariya, R., Ge, Y., & Mohamadzadeh, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062973 · Cited by 519
Structural insights into the lipid and ligand regulation of serotonin receptors
Xu, P., Huang, S., Zhang, H., Mao, C., Zhou, X. E., Cheng, X., Simon, I. A., Shen, D.-D., Yen, H.-Y., Robinson, C. V., et al. (2021) · Nature · doi:10.1038/s41586-021-03376-8 · Cited by 270
The neurobiology of social play behaviour: Past, present and future
Achterberg, E. J. M., & Vanderschuren, L. J. M. J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105319 · Cited by 56
Metadata
- Authors
- Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., Di Giovanni, G., Goodfellow, N. M., Halberstadt, A. L., Hartley, R. M., Hassaine, G., Herrick-Davis, K., Hovius, R., Lacivita, E., Lambe, E. K., Leopoldo, M., Levy, F. O., Lummis, S. C. R., Marin, P., Maroteaux, L., McCreary, A. C., Nelson, D. L., Neumaier, J. F., Newman-Tancredi, A., Nury, H., Roberts, A., Roth, B. L., Roumier, A., Sanger, G. J., Teitler, M., Sharp, T., Villalón, C. M., Vogel, H., Watts, S. W., & Hoyer, D.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 73
- Issue
- 1
- Pages
- 310-520
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W3116452987
- Cited by
- 263
- References
- 2,264
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.